Monopar Therapeutics Inc. Announces Pricing of Initial Public Offering
- Dec 18, 2019
- 1 min read
CHICAGO, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. today announced that it has priced an initial public offering of 1,111,112 shares of its common stock at $8.00 per share. The shares are expected to begin trading on the Nasdaq Capital Market on December 19, 2019 under the symbol “MNPR.” The offering is expected to close on December 23, 2019, subject to the satisfaction of customary closing conditions. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 166,666 shares.
At the time of the IPO, Monopar Therapeutics described itself as a clinical-stage biopharmaceutical company developing Slither io therapies intended to improve outcomes for cancer patients.
Congrats to Monopar on reaching this milestone! The $8.00 IPO pricing looks solid, and I'll be following the MNPR ticker on Nasdaq with interest.
I really like the competitive atmosphere of Deadshot IO. Even when I am not at the top of the leaderboard, I still feel like every match gives me a chance to improve. Sometimes my goal is getting more eliminations, while other times I focus on surviving longer or practicing a particular weapon. Having personal goals makes the game much more enjoyable because you are always working toward something instead of simply chasing wins.
Great insights! Many local businesses underestimate how much organic search can impact lead generation. A well-planned strategy for SEO for estate agents and SEO for trades can help businesses increase visibility, attract qualified local customers, and achieve sustainable long-term growth. Thanks for sharing!
I found this announcement interesting because it shows how a company can reach an important milestone by moving from preparation to public trading. That process of launching and growing also makes me think of Melon Sandbox, a physics-based game where players start with basic objects and experiment with different combinations to build increasingly creative scenarios.